4SC AG INH. O.N./ DE000A3E5C40 /
2024-05-22 12:21:15 PM | Chg. -0.0200 | Volume | Bid9:58:01 PM | Ask9:58:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.7600EUR | -0.26% | 570 Turnover: 4,548.2000 |
-Bid Size: - | -Ask Size: - | 78.48 mill.EUR | 0.00% | - |
GlobeNewswire
2023-12-05
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
2019-04-01
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
2018-06-11
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018